Dr. Shirley Oga Koeck, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 69630 Stirling Blvd, Covington, LA 70433 Phone: 985-327-6258 |
Dr. Aimee Brady Chilton, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1431 Ochsner Blvd Ste A, Covington, LA 70433 Phone: 985-875-7898 Fax: 985-875-9844 |
Dr. Amanda Hickman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1107 Village Walk, Covington, LA 70433 Phone: 985-231-0800 Fax: 985-590-3721 |
Dr. Mark Siverd, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 880 N Highway 190, Covington, LA 70433 Phone: 985-867-8708 |
Joseph V Sica Sr A Professional Optometric Corp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 312 S Jefferson Ave, Covington, LA 70433 Phone: 985-892-2722 Fax: 985-892-3418 |
News Archive
We, as most animals, host many different beneficial bacteria. Being beneficial to the host often pays off for the bacteria, as success of the host determines the survival and spread of the microbe. But if bacteria grow too much they may become deadly.
ThermoGenesis Corp., a leading supplier of innovative products for processing and storing adult stem cells, said today its Res-Q(TM) 60 BMC ("Res-Q") System has demonstrated positive outcomes in its initial applications, according to its orthopedic distribution partner Celling Technologies, a subsidiary of SpineSmith, LLC.
Peering into the DNA of tiny yeast, researchers at the Moores Cancer Center at the University of California, San Diego and the San Diego Branch of the Ludwig Institute for Cancer Research have pinpointed a large number of genes that can prevent a type of genetic rearrangement that may lead to cancer and other diseases.
Researchers have studied the effects of too much social networking among young girls and found that it is ruining their girlhood. The new Stanford University study looks at data from girls between the ages of 8 and 12 who spend "considerable" time using social media and finds that they are likely to be "less happy" than their unplugged peers.
Today, the U.S. Food and Drug Administration granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
› Verified 9 days ago